Señales en vivo de ADTX | Maximiza tus Ganancias con Getagraph.com

VENDER 108065 min ago

@ $4.00

Emitido: 13 feb 2024 @ 14:29

Retorno: -40.25%

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	65 262.00
Volumen promedio	372 577
Capitalización de mercado	4.69M
EPS	$0 ( 2024-04-02 )
Próxima fecha de ganancias	( $-3.33 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0.0500 (2.08%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-08	Runge Jeffrey W.	Buy	470	Options (right to buy)
2023-11-08	Albanna Rowena	Buy	4 702	Options (right to buy)
2023-11-08	Nelson Charles Athle	Buy	470	Options (right to buy)
2023-11-08	Albanna Amro A.	Buy	9 404	Options (right to buy)
2023-11-08	Pankovcin Corinne	Buy	4 702	Options (right to buy)

INSIDER POWER
26.52
Last 84 transactions
Buy: 1 934 500 \| Sell: 1 185 103

Volumen Correlación

Largo: 0.10 (neutral)

Corto: -0.80 (moderate negative)

Signal:(42.192) Neutral

ADiTx Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas
OGI	0.974
BNGO	0.971
VERB	0.971
CNXC	0.968
IMBI	0.965
NESR	0.965
MRIN	0.964
WATT	0.963
MMAT	0.962
DISH	0.961

10 Correlaciones Más Negativas
MSDA	-0.971
ADAL	-0.966
TIOAU	-0.961
TIOA	-0.961
BRIV	-0.96
LEGA	-0.959
ZING	-0.959
SKYA	-0.958
CRZN	-0.957
VLAT	-0.957

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ADiTx Therapeutics, Inc. Correlación - Moneda/Commodity

0.65
( weak )

0.62
( weak )

0.00
( neutral )

0.55
( weak )

-0.26
( neutral )

-0.46
( neutral )

ADiTx Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$645 176
Beneficio Bruto:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2023
Ingresos:	$645 176
Beneficio Bruto:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2022
Ingresos:	$933 715
Beneficio Bruto:	$166 936 (17.88 %)
EPS:	$-608.04

FY	2021
Ingresos:	$105 034
Beneficio Bruto:	$27 055.00 (25.76 %)
EPS:	$-6.72

Financial Reports:

No articles found.

ADiTx Therapeutics, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.